Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2011
Total Assets: $1.98B
Liabilities Breakdown FY2011
Total Liabilities: $653.1M
Asset Breakdown
Total Assets: $1.98B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $171.2M | 8.6% |
| Accounts Receivable | $283.8M | 14.3% |
| Inventory | $261.3M | 13.2% |
| Property, Plant & Equipment | $304.3M | 15.4% |
| Goodwill | $349.8M | 17.7% |
| Intangible Assets | $66.9M | 3.4% |
| Other Assets | $543.2M | 27.4% |
Liabilities Breakdown
Total Liabilities: $653.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $85.0M | 13.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $568.1M | 87.0% |